Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80
OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg Recall: Crescent Pharma Limited is initiating a
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited KingdomPublishedMay 28, 2026Last updatedMay 28, 2026Official source last checkedSeptember 9, 2026 at 1:48 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
Hazard
Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
What consumers should do
for Healthcare Professionals: stop supplying the impacted batch of Ramipril 2.5mg Capsules (batch number GR155023) immediately. Quarantine all remaining stock and return it to your supplier using your approved process Consideration of the following patient communication should be considered within 48 hours of the alert and actioned within 5 working days: if batch/product traceability information is available, healthcare professionals involved in dispensing medicinal products should contact all patients who have been dispensed the impacted product and ask them to inspect the packs they have in their possession if batch/product traceability information is not available, pharmacists should identify all patients dispensed this product between 16 Jan 2026 and 22 May 2026. Attempts should be made to contact patients who have been dispensed the impacted product within the last 28 days as a priority any patients with impacted packs should be told to stop taking them immediately, return them to the pharmacy and contact their GP practice. Patients with non-impacted packs (majority of patients) should be informed they may continue to take the capsules from this batch where patients are identi
Official recall notice
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: May 28, 2026
Read the official UK_MHRA recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
